Literature DB >> 23825383

The increasing role of pharmacists in antimicrobial stewardship in English hospitals.

H J Wickens1, S Farrell, D A I Ashiru-Oredope, A Jacklin, A Holmes.   

Abstract

OBJECTIVES: To evaluate the development of pharmacist-led antimicrobial stewardship activities in English hospitals.
METHODS: Distribution of an electronic questionnaire to antimicrobial pharmacists or chief pharmacists in National Health Service hospitals in England.
RESULTS: Since a previous study, in 2005, overall numbers of specialist antimicrobial pharmacists, and their levels of experience, had increased. Over 95% of hospitals provided empirical usage guidance, antimicrobial formularies and surgical prophylaxis guidelines. Two-thirds of pharmacy departments provided antimicrobial usage reports in terms of defined daily doses at least yearly, and over 80% conducted yearly antimicrobial point prevalence studies. The vast majority of pharmacy departments indicated a willingness to supply data and audit results to a national database for benchmarking purposes.
CONCLUSIONS: The increasing role of specialist pharmacists and general pharmacists in antibiotic stewardship in acute care in England has enabled hospitals to deliver on the antibiotic stewardship agenda, although opportunity remains to expand this role further and ensure greater multidisciplinary engagement.

Keywords:  antibiotic policy; pharmacy; prescribing

Mesh:

Substances:

Year:  2013        PMID: 23825383     DOI: 10.1093/jac/dkt241

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  22 in total

1.  Antimicrobial stewardship activities in hospitals in Ireland and the United Kingdom: a comparison of two national surveys.

Authors:  Aoife Fleming; Antonella Tonna; Síle O'Connor; Stephen Byrne; Derek Stewart
Journal:  Int J Clin Pharm       Date:  2015-04-08

Review 2.  Antimicrobial resistance (AMR).

Authors:  Steffen Amann; Kees Neef; Stephanie Kohl
Journal:  Eur J Hosp Pharm       Date:  2019-05-07

3.  Impact of clinical pharmacist intervention on antimicrobial use in a small 164-bed hospital.

Authors:  Pedro Mas-Morey; Alfonso Ballesteros-Fernández; Elisabet Sanmartin-Mestre; Marta Valle
Journal:  Eur J Hosp Pharm       Date:  2017-11-01

4.  A systematic review of inpatient antimicrobial stewardship programmes involving clinical pharmacists in small-to-medium-sized hospitals.

Authors:  Pedro Mas-Morey; Marta Valle
Journal:  Eur J Hosp Pharm       Date:  2017-12-16

5.  What influences the implementation and sustainability of antibiotic stewardship programmes in hospitals? A qualitative study of antibiotic pharmacists' perspectives across South West England.

Authors:  Teerapong Monmaturapoj; Jenny Scott; Paula Smith; Margaret C Watson
Journal:  Eur J Hosp Pharm       Date:  2021-03-31

6.  Mapping Antimicrobial Stewardship in Undergraduate Medical, Dental, Pharmacy, Nursing and Veterinary Education in the United Kingdom.

Authors:  Enrique Castro-Sánchez; Lydia N Drumright; Myriam Gharbi; Susan Farrell; Alison H Holmes
Journal:  PLoS One       Date:  2016-02-29       Impact factor: 3.240

Review 7.  Role of the pharmacist in reducing healthcare costs: current insights.

Authors:  Kieran Dalton; Stephen Byrne
Journal:  Integr Pharm Res Pract       Date:  2017-01-25

Review 8.  Preventing drug-related adverse events following hospital discharge: the role of the pharmacist.

Authors:  Justine Nicholls; Craig MacKenzie; Rhiannon Braund
Journal:  Integr Pharm Res Pract       Date:  2017-02-13

9.  Antimicrobial Stewardship from Policy to Practice: Experiences from UK Antimicrobial Pharmacists.

Authors:  Mark Gilchrist; Paul Wade; Diane Ashiru-Oredope; Philip Howard; Jacqueline Sneddon; Laura Whitney; Hayley Wickens
Journal:  Infect Dis Ther       Date:  2015-09-11

10.  Antimicrobial Time-Out for Vancomycin by Infectious Disease Physicians Versus Clinical Pharmacists: A Before-After Crossover Trial.

Authors:  Shinya Hasegawa; Yasuaki Tagashira; Shutaro Murakami; Yasunori Urayama; Akane Takamatsu; Yuki Nakajima; Hitoshi Honda
Journal:  Open Forum Infect Dis       Date:  2021-03-14       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.